44 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
to the unpredictable nature of the pandemic and related Captisol sales, Ligand excludes Captisol sales related to COVID-19 from guidance and will update investors
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
strategic growth plan and continue the development of its proprietary programs; the COVID-19 pandemic and any future epidemic diseases could adversely
8-K
EX-99.1
m2agtrtne d7
7 Nov 22
Ligand Reports Third Quarter 2022 Financial Results
4:04pm
8-K
EX-99.1
nup ycukp691diiur0
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
si7q 9huw2b
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
3to651v zntu7s3
21 Jun 22
Regulation FD Disclosure
6:19am
425
inmsfiwt
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
5v2mck 15u8
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
x8fy9
24 Mar 22
Business combination disclosure
9:09am
8-K
q32d8y3cibc6h
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.2
6g1h3zws0y9p11f2k
23 Mar 22
Business combination disclosure
5:29pm
425
7gcb5iirgtv7t2of
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.1
x2w4y3y x49142r
23 Mar 22
Business combination disclosure
5:29pm
8-K
EX-99.1
vhx72fdej drtsu
23 Mar 22
Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II
5:25pm